Stockreport

Sonoma Pharmaceuticals Announces U.S. Commercialization of Loyon® for Relief of Scaling, Burning and Itching Associated with Various Dermatoses Including Seborrhea and Seborrheic Dermatiti...

Sonoma Pharmaceuticals, Inc.  (SNOA) 
Last sonoma pharmaceuticals, inc. earnings: 2/14 05:13 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.sonomapharma.com
PDF PETALUMA, Calif., Oct. 03, 2017 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA, warrants SNOAW), a specialty pharmaceutical company that develops and m [Read more]